清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: A systematic review and meta-analysis

医学 肝细胞癌 肝移植 内科学 荟萃分析 米兰标准 癌 移植 胃肠病学 外科
作者
Daniel A. Butcher,Kelli J. Brandis,Haolu Wang,Liam Spannenburg,Kim R. Bridle,Dorothy H. Crawford,Xiaowen Liang
出处
期刊:Ejso [Elsevier BV]
卷期号:48 (3): 621-631 被引量:10
标识
DOI:10.1016/j.ejso.2021.09.017
摘要

The aim of this meta-analysis was to conduct a contemporary systematic review of high quality non-randomised controlled trials to determine the effect of pre-liver transplantation (LT) transarterial chemoembolisation (TACE) on long-term survival and complications of hepatocellular carcinoma (HCC) patients.TACE is used as a neoadjuvant therapy to mitigate waitlist drop-out for patients with HCC awaiting LT. Previous studies have conflicting conclusions on the effect of TACE on long-term survival and complications of HCC patients undergoing LT.CINAHL, Cochrane Controlled Register of Trials, Embase, PubMed, and Web of Science were systematically searched. Baseline characteristics included number of patients outside Milan criteria, tumour diameter, MELD score, and time on the waiting list. Primary outcomes included 3- and 5-year overall and disease-free survival. Secondary outcomes included tumour recurrence, 30-day postoperative mortality, and hepatic artery and biliary complications.Twenty-one high-quality NRCTs representing 8242 patients were included. Tumour diameter was significantly larger in TACE patients (3.49 cm vs 3.15 cm, P = 0.02) and time on the waiting list was significantly longer in TACE patients (4.87 months vs 3.46 months, P = 0.05), while MELD score was significantly higher in non-TACE patients (10.81 vs 12.35, P = 0.005). All primary and secondary outcomes displayed non-significant differences.Patients treated with TACE had similar survival and postoperative outcomes to non-TACE patients, however, they had worse prognostic features compared to non-TACE patients. These findings strongly support the current US and European clinical practice guidelines that neoadjuvant TACE can be used for patients with longer expected waiting list times (specifically >6 months). Randomised controlled trials would be needed to increase the quality of evidence.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被纯情的阁采纳,获得10
5秒前
5秒前
故意的冷安完成签到,获得积分10
7秒前
12秒前
坚定的咖啡完成签到,获得积分10
12秒前
冷艳千柳完成签到,获得积分10
12秒前
15秒前
31秒前
31秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
32秒前
科研通AI6.4的应助被纯情的阁采纳,获得30
32秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
32秒前
池雨完成签到 ,获得积分10
47秒前
苗条的香萱完成签到,获得积分10
55秒前
年轻狗完成签到,获得积分10
1分钟前
1分钟前
1分钟前
研友_nqrKQZ发布了新的文献求助10
1分钟前
隐形曼青的应助被研友_nqrKQZ采纳,获得10
1分钟前
1分钟前
爱听歌的语堂完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
搞怪山河完成签到,获得积分10
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
星辰大海的应助被天熙采纳,获得10
1分钟前
纯情的阁发布了新的文献求助30
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得30
1分钟前
1分钟前
1分钟前
xun发布了新的文献求助10
1分钟前
1分钟前
天熙发布了新的文献求助10
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158905
求助须知:如何正确求助?哪些是违规求助? 9554522
关于积分的说明 21719373
捐赠科研通 7748459
什么是DOI,文献DOI怎么找? 3427107
关于科研通互助平台的介绍 2552006
邀请新用户注册赠送积分活动 2471370